Tenet Healthcare board to review Community Health Systems' revised all-cash proposal

NewsGuard 100/100 Score

Tenet Healthcare Corporation (NYSE: THC) today confirmed that it has received a revised proposal from Community Health Systems, Inc. (NYSE: CYH) to acquire all of the outstanding shares of Tenet for $6.00 per share in cash.

Consistent with its fiduciary duties and in consultation with its independent financial and legal advisors, Tenet's Board of Directors will review the revised proposal to determine the course of action that it believes is in the best interests of the Company and its shareholders.  Tenet's shareholders are advised to take no action at this time pending the review of the revised proposal by the Tenet Board of Directors.

Tenet noted that the Community Health revised proposal is for the same price as a previous Community Health proposal received by Tenet on November 12, 2010. On December 6, 2010, the Tenet Board of Directors, after consultation with its financial and legal advisors, sent a letter to Community Health stating that it had unanimously determined that the Community Health proposal grossly undervalued Tenet and was not in the best interests of Tenet or its shareholders.

Barclays Capital is acting as financial advisor to Tenet and Gibson, Dunn & Crutcher LLP and Debevoise & Plimpton LLP are acting as Tenet's legal counsel.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Top minds in multiple sclerosis to speak at CMSC 38th Annual Meeting